Synopsys Q1 FY2023 revenue $1.361B, GAAP EPS $1.75, non-GAAP EPS $2.62; reaffirms FY guidance

SYNOPSYS INC

2023-Q1 EPS reported $1.75 revenue$1,361,340,000

Revenue $1.361B vs $1.270B YoY; GAAP EPS $1.75 (down from $1.99), non-GAAP EPS $2.62 (up from $2.40).
Changed reportable segments to three: Design Automation, Design IP, Software Integrity effective Q1 FY2023.
Reaffirmed FY2023 targets: 14-15% revenue growth, non-GAAP operating margin expansion, non-GAAP EPS growth 18-19%.
Updated annual non-GAAP tax rate to 16% for FY2023 from 18% due to R&D capitalization rules.
CEO Aart de Geus cited robust design activity as driver of confidence and guidance reaffirmation.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SYNOPSYS INC reported Q1 FY23 results: net income $406.7 million, EPS $2.62.

Period: Q1 FY23
Net income: $406.7 million
EPS: $2.62
Result: reported results

Exact text from the filing

Synopsys Posts Financial Results for First Quarter Fiscal Year 2023 Q1 FY 2023 Financial Highlights • Revenue: $1.361 billion • GAAP earnings per diluted share: $1.75 • Non-GAAP earnings per diluted share: $2.62

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SYNOPSYS INC reported Q1 FY23 results: net income $406.7 million, EPS $2.62.

Period: Q1 FY23
Net income: $406.7 million
EPS: $2.62
Result: reported results

Exact text from the filing

On a non-GAAP basis, net income for the first quarter of fiscal year 2023 was $406.7 million, or $2.62 per diluted share

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

SYNOPSYS INC filing history →

Source: SEC EDGAR

accession 0001193125-23-040255

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.